These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26560137)

  • 21. Insulin analogues in the management of diabetes.
    Vázquez-Carrera M; Silvestre JS
    Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undeniable need for ultrafast-acting insulin: the pediatric perspective.
    Cengiz E
    J Diabetes Sci Technol; 2012 Jul; 6(4):797-801. PubMed ID: 22920804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous insulin infusion systems in type 2 diabetes.
    Kesavadev J
    J Assoc Physicians India; 2011 Apr; 59 Suppl():41-3. PubMed ID: 21818997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in diabetes for the millennium: insulin treatment and glucose monitoring.
    Einhorn D
    MedGenMed; 2004 Sep; 6(3 Suppl):8. PubMed ID: 15647713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus evidence-based guidelines for use of insulin pump therapy in the management of diabetes as per Indian clinical practice.
    Kesavadev J; Jain SM; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):34-41. PubMed ID: 25668935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy, safety and indication of newly developed insulin analogs].
    Kobayashi T
    Nihon Rinsho; 2001 Nov; 59(11):2165-72. PubMed ID: 11712402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas.
    Shimoda S; Nishida K; Sakakida M; Konno Y; Ichinose K; Uehara M; Nowak T; Shichiri M
    Front Med Biol Eng; 1997; 8(3):197-211. PubMed ID: 9444512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop.
    Hanaire H
    Diabetes Metab; 2006 Dec; 32(5 Pt 2):534-8. PubMed ID: 17130814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice.
    Rossetti P; Ampudia-Blasco FJ; Ascaso JF
    Diabetes Obes Metab; 2014 Aug; 16(8):695-706. PubMed ID: 24401118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision Dosing of Rapid-Acting Insulin Matters.
    Aanstoot HJ; Rodriguez H; Weinzimer S; Vint N; Koeneman L
    Diabetes Technol Ther; 2020 May; 22(5):346-351. PubMed ID: 32125891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery.
    Klonoff DC
    Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fulfilling the promise of insulin pump therapy in childhood diabetes.
    Tamborlane WV
    Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An online failure detection method of the glucose sensor-insulin pump system: improved overnight safety of type-1 diabetic subjects.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    IEEE Trans Biomed Eng; 2013 Feb; 60(2):406-16. PubMed ID: 23193300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern clinical management helps reducing the impact of type 1 diabetes in children.
    Scaramuzza AE; Zuccotti GV
    Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using technology to advance type 1 diabetes care among women during the reproductive years and in pregnancy.
    Polsky S; Giordano D; Voelmle MK; Garcetti R; Garg SK
    Postgrad Med; 2016 May; 128(4):418-26. PubMed ID: 26924774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can Faster Aspart Be Used to Optimize Glycemic Control With Insulin Pump Therapy? From Expectations to Lessons Learned After a Year of Use in the United States.
    Aleppo G; Bode B; Carlson AL
    Clin Diabetes; 2022; 40(4):413-424. PubMed ID: 36381308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.